-
METHODOLOGICAL CHARACTERISTICS OF PHARMACOGENOMICS-INTEGRATED AI CLINICAL DECISION SUPPORT SYSTEMS (AI-CDSS): A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
DIFFERENCES IN PATIENT CHARACTERISTICS AND OUTCOMES BY MEDICATION ADHERENCE AMONG US ADULTS TREATED FOR HIGH CHOLESTEROL
Mar 18, 2026, 21:38 PM -
REAL-WORLD HEALTHCARE UTILIZATION AND CLINICAL CHARACTERISTICS ACROSS DIABETES COMPLICATIONS SEVERITY IN MEDICARE ADVANTAGE INSURED ADULTS WITH TYPE 2 DIABETES
Mar 18, 2026, 21:38 PM -
LEARNING THE CAUSAL STRUCTURE OF MENTAL HEALTH LITERACY DIMENSIONS FROM OBSERVATIONAL DATA: A MULTI-METHOD CAUSAL DISCOVERY STUDY
Mar 18, 2026, 21:38 PM -
THE ECONOMIC BURDEN ON FAMILIES OF CHILDREN WITH TYPE 1 SPINAL MUSCULAR ATROPHY IN BRAZIL
Mar 18, 2026, 21:38 PM -
A PILOT STUDY APPLYING MACHINE LEARNING (ML) TO IDENTIFY PREDICTORS OF HIGH-COST CARE AMONG ADULTS WITH NON-HODGKIN LYMPHOMA (NHL) USING MEPS 2020-2023
Mar 18, 2026, 21:38 PM -
VALIDATING PRIMARY AND SECONDARY HEALTHCARE RESOURCE USE AND COSTS ESTIMATES IN OMOP-MAPPED VS SOURCE CPRD-HES DATA IN THE UK
Mar 18, 2026, 21:38 PM -
ASSESSING THE RETURN ON INVESTMENT (ROI) OF HEOR & RWE TO THE BIOPHARMACEUTICAL INDUSTRY: CASE EXAMPLE OF COMPARATIVE EFFECTIVENESS RESEARCH USING SECONDARY RWD SOURCES
Mar 18, 2026, 21:38 PM -
PROVISIONAL PRICING IN MEDICINE POLICY: GLOBAL BENCHMARKING
Mar 18, 2026, 21:38 PM -
MICROSIMULATION-BASED COST EFFECTIVENESS ANALYSIS OF INTEGRATED CARDIOMETABOLIC HEALTH SCREENING IN THE UNITED KINGDOM, GERMANY, FRANCE, AND AUSTRALIA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF FITUSIRAN PROPHYLAXIS VERSUS FACTOR VIII ON-DEMAND OR PROPHYLACTIC THERAPY FOR HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
Mar 18, 2026, 21:38 PM -
LINKING QUALITY AND FINANCIAL PERFORMANCE: A FIVE-YEAR LONGITUDINAL ANALYSIS OF ROI IN MEDICARE PIONEER ACOS
Mar 18, 2026, 21:38 PM -
AVOIDABLE DIRECT COSTS IN PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) TREATED WITH DAROLUTAMIDE: A REAL-WORLD EVIDENCE FROM A MULTICENTER STUDY IN COLOMBIA
Mar 18, 2026, 21:38 PM -
REAL-WORLD ASSESSMENT OF OPIOID AND HEALTH ECONOMIC OUTCOMES IN MEDICARE ADVANTAGE BENEFICIARIES UNDERGOING TOTAL SHOULDER ARTHROPLASTY
Mar 18, 2026, 21:38 PM -
AN EXPANDED ANALYSIS OF WHICH FEATURES CONVEY EMPATHY TO PATIENTS IN SCIENTIFIC WRITING
Mar 18, 2026, 21:38 PM -
PSYCHIATRIC MORBIDITY AMONG INDIVIDUALS WITH INHERITED RETINAL DISEASE- A NATIONWIDE SWEDISH RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
COPD IN THE UNITED STATES: FACTORS AFFECTING TREATMENT PATTERNS AND UTILIZATION OF PHARMACOTHERAPY
Mar 18, 2026, 21:38 PM -
RAPID AI-ENABLED PICO SCOPING TO SUPPORT EUROPEAN JOINT CLINICAL ASSESSMENTS: A 4TH-LINE METASTATIC COLORECTAL CANCER CASE STUDY
Mar 18, 2026, 21:38 PM -
REGULATORY CHALLENGES AND INSIGHTS FROM FDA IN 2025; POTENTIAL IMPLICATIONS OF THE PLAUSIBLE MECHANISM PATHWAY AND SUBSEQUENT HEALTH TECHNOLOGY ASSESSMENTS
Mar 18, 2026, 21:38 PM -
DIFFERENCES IN THE DIETARY HABITS AND RISK FACTORS FOR METABOLIC DISEASES BETWEEN WESTERN AND EASTERN EUROPE
Mar 18, 2026, 21:38 PM
